drugset / Trial / NCT00770796

Statins for Prevention of Contrast Induced Nephropathy

NCT00770796 ↗

Phase 4 Completed 304 enrolled Ospedale Misericordia e Dolce
RandomizedParallel-groupQuadruple-blindPrevention

Summary

In this randomized study the investigators wish to explore the role of pre-procedural statin therapy for the prevention of contrast induced nephropathy in patients with moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.

Timeline

Start
2006-04
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 80 mg —